that’s the thing with biotech, drug discovery & clinical trials ….
you don’t have the answers and maybe its not the right place for your investment …
dates have always been what they are (ironically very similar to akki’s calls he was lambasted for years on with these threads lol)
preliminary data end of year FDA submissions and outcomes 2025 …
if they want more & don’t granted accelerated approval then validity of the voucher comes into question
- Forums
- ASX - By Stock
- PER
- Ann: Phase IIb study of ATL1102 in DMD completes recruitment
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-141
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.0¢ | $277.9K | 24.26M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 2273797 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 5066000 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 2223797 | 0.010 |
8 | 6438144 | 0.009 |
3 | 975000 | 0.008 |
3 | 1585000 | 0.007 |
1 | 1000000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 280000 | 1 |
0.011 | 2466000 | 5 |
0.012 | 2818324 | 6 |
0.013 | 791461 | 4 |
0.014 | 1572000 | 3 |
Last trade - 16.14pm 26/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online